JOURNEY MEDICAL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.69 USD | +1.65% |
|
+8.53% | -35.94% |
| 05-01 | Journey Medical Corporation Appoints Joseph M. Benesch as Chief Financial Officer | CI |
| 03-21 | Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024 |
Chart calendar Journey Medical Corporation
52a1721676ea7f9d7d2f50fcd.mKwjG8geQNDBVNynSxi54tgComIxc9U8pX9I9nUAuz4.8-oUUa8tApKZDb_TfU3vrr5Y2jVEGIFYzTsBmTNI8nypynFY_isY44pj6A~c528fd9af81ea73fff6aa902e8c9bea8
Upcoming events on Journey Medical Corporation
Past events on Journey Medical Corporation
| 01/05/2024 17:00 | Planet MicroCap Showcase |
| 21/03/2024 20:30 | Q4 2023 Earnings Call |
| 21/03/2024 20:01 | Q4 2023 Earnings Release |
| 18/03/2024 16:30 | ROTH Conference - Fireside Chat |
| 07/03/2024 | American Academy of Dermatology Meeting |
| 07/11/2023 21:30 | Q3 2023 Earnings Call |
| 07/11/2023 21:01 | Q3 2023 Earnings Release |
| 08/08/2023 21:30 | Q2 2023 Earnings Call |
| 08/08/2023 21:01 | Q2 2023 Earnings Release |
| 21/06/2023 16:00 | Annual General Meeting |
| 22/05/2023 21:30 | Q1 2023 Earnings Call |
| 22/05/2023 17:01 | Q1 2023 Earnings Release |
| 29/03/2023 21:30 | Q4 2022 Earnings Call |
| 29/03/2023 21:01 | Q4 2022 Earnings Release |
| 14/03/2023 16:30 | ROTH Conference |
| 08/12/2022 14:00 | Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference - Panel |
| 10/11/2022 21:30 | Q3 2022 Earnings Call |
| 10/11/2022 21:01 | Q3 2022 Earnings Release |
| 25/10/2022 23:00 | LD Micro Main Event Conference |
| 06/10/2022 17:15 | Roth Healthcare Opportunities Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 63,1 66,0 -4.34% | 73,7 74,3 -0.83% | 79,2 79,0 0.27% | 58,0 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -29,8 -19,7 -51.32% | -7,28 -8,15 10.58% | 15,6 16,7 -6.83% | 3,94 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -34,9 -25,6 -36.01% | -27,5 -26,2 -4.91% | -2,07 -1,07 -93.56% | -14,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -42,4 -34,6 -22.42% | -29,6 -27,9 -6.11% | -3,63 -3,26 -11.57% | -15,1 |
|
Net income Million USD | Released Forecast Spread | 5,28 | -44,0 -27,5 -60.25% | -29,6 -27,3 -8.35% | -3,85 -3,30 -16.65% | -15,1 |
|
EPS USD | Released Forecast Spread | 0,49 | -4,32 -2,62 -64.89% | -1,69 -1,56 -8.57% | -0,21 -0,18 -20% | -0,74 |
| Announcement Date | 22/07/21 | 28/03/22 | 29/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,5 20,4 -14.13% | 23,3 22,2 5.11% | 18,3 21,3 -14.16% | 16,1 17,7 -8.71% | 16,0 16,6 -3.7% | 12,2 16,2 -24.5% | 17,2 14,8 15.97% | 34,5 16,9 104.65% | 15,3 15,0 2.01% | 14,1 | 14,5 | 14,7 | 14,7 |
|
EBITDA Million USD | Released Forecast Spread | -4,71 -1,88 -150.56% | 2,31 1,21 91.54% | -2,57 -0,07 -3572.86% | -4,02 -3,79 -6.15% | -3,00 -3,86 22.31% | -5,86 -1,46 -301.37% | -0,64 -1,80 64.44% | 20,8 2,36 781.17% | 0,72 1,87 -61.24% | 0,14 | 1,12 | 1,31 | 1,38 |
|
EBIT Million USD | Released Forecast Spread | -9,06 -4,60 -96.76% | -0,89 -5,00 82.24% | -7,14 -4,79 -49.12% | -9,49 -8,10 -17.19% | -10,00 -8,72 -14.65% | -9,56 -7,84 -21.95% | -7,65 -6,68 -14.57% | 17,2 -3,70 566.71% | -2,10 -1,27 -65.15% | -4,40 | -3,81 | -3,19 | -3,30 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,4 -5,64 -137.94% | -1,27 -4,42 71.19% | -7,59 -4,97 -52.7% | -10,1 -8,71 -15.67% | -10,6 -8,94 -18.91% | -10,1 -7,98 -27.08% | -8,36 -6,91 -20.95% | 16,9 -2,83 696.92% | -2,02 -1,73 -16.83% | -4,63 | -3,83 | -3,30 | -3,31 |
|
Net income Million USD | Released Forecast Spread | -21,8 -5,22 -316.34% | -1,38 -4,42 68.84% | -7,53 -4,75 -58.47% | -10,1 -8,71 -15.79% | -10,6 -8,35 -27.39% | -10,1 -7,98 -27% | -8,36 -6,91 -20.95% | 16,8 -2,83 693.57% | -2,14 -1,73 -24.12% | -4,63 | -3,83 | -3,30 | -3,31 |
|
EPS USD | Released Forecast Spread | -1,89 -0,41 -357.26% | -0,08 -0,31 74.19% | -0,43 -0,26 -67.53% | -0,57 -0,40 -43.7% | -0,60 -0,47 -28.57% | -0,57 -0,45 -27.61% | -0,46 -0,34 -37.31% | 0,80 -0,16 616.13% | -0,12 -0,09 -41.18% | -0,24 | -0,20 | -0,17 | -0,16 |
| Announcement Date | 28/03/22 | 10/05/22 | 09/08/22 | 10/11/22 | 29/03/23 | 22/05/23 | 08/08/23 | 07/11/23 | 21/03/24 | - | - | - | - |
| 06/05/2024 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release (Projected) |
| 06/05/2024 | EVOLUS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | DR. REDDY'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 06/05/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | BLAU FARMACÊUTICA S.A.: Q1 2024 Earnings Release |
| 07/05/2024 11:30 | PERRIGO COMPANY PLC: Q1 2024 Earnings Release |
| 07/05/2024 21:00 | OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release |
| 07/05/2024 21:01 | LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected) |
Past sector events for Journey Medical Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DERM Stock
- Calendar Journey Medical Corporation
